medroxyprogesterone acetate has been researched along with Arteriosclerosis in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.00) | 18.7374 |
| 1990's | 10 (50.00) | 18.2507 |
| 2000's | 9 (45.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Honjo, H; Hosoda, T; Kitawaki, J; Tanaka, K; Tatsumi, H | 1 |
| Anthony, MS; Clarkson, TB; Rankin, SE; Shadoan, MK; Wagner, JD | 1 |
| Appt, SE; Clarkson, TB | 1 |
| Pradhan, S; Sumpio, BE | 1 |
| Knopp, RH; Leboeuf, RC; Rosenfeld, ME; Shultz, JM; Zhu, XD | 1 |
| Al Zubaidy, AJ; Al-Hashimi, AS; Al-Shebib, TH | 1 |
| Anthony, MS; Clarkson, TB; Herrington, DM; Honoré, EK; Morgan, TM; Register, TC; Williams, JK | 1 |
| Chutivongse, S; de La Cruz, DL; Garza-Flores, J; George, P; Joyce, S; Kongsayreepong, R; McCone, JM; Perez-Palacios, G; Rosseneu, M; Valles de Bourges, V | 1 |
| Chung, TK; Haines, CJ; Lau, JT; Masarei, JR; Tomlinson, B | 1 |
| Anthony, MS; Cefalu, WT; Clarkson, TB; Jayo, MJ; Martino, MA; Wagner, JD | 1 |
| Doyle, MC; Feely, J; Harrison, RF; Wen, Y | 1 |
| Ernster, VL; Grady, D | 1 |
| Adams, MR; Clarkson, TB; Golden, DL; Register, TC | 1 |
| Aygen, EM; Başbuğ, M; Kaya, E; Tayyar, M | 1 |
| Barnabei, VM; Hsia, J; Phillips, TM | 1 |
| Husmann, F | 1 |
| Honjo, H; Iwasa, K; Kikuchi, N; Okubo, T; Tsuchiya, H; Urabe, M; Yamamoto, T; Yokota, K | 1 |
| Naessen, T | 1 |
| Dastidar, P; Jaakkola, O; Jokela, H; Koivu, TA; Koivula, T; Lehtimäki, T; Nikkari, ST; Punnonen, R | 1 |
| Allam, G; Alloush, M; Fahmy, K; Gobran, F; Khairy, M | 1 |
2 review(s) available for medroxyprogesterone acetate and Arteriosclerosis
| Article | Year |
|---|---|
MPA and postmenopausal coronary artery atherosclerosis revisited.
Topics: Animals; Antineoplastic Agents, Hormonal; Arteriosclerosis; Breast Neoplasms; Cholesterol, HDL; Contraceptive Agents, Female; Contraceptives, Oral; Coronary Vessels; Estrogens; Female; Haplorhini; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Menopause; Models, Biological; Postmenopause; Risk | 2003 |
Do estrogen effects on blood vessels translate into clinically significant atheroprotection?
Topics: Animals; Arteriosclerosis; Climacteric; Clinical Trials as Topic; Drug Therapy, Combination; Endothelium, Vascular; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Humans; Lipids; Medroxyprogesterone Acetate | 2004 |
4 trial(s) available for medroxyprogesterone acetate and Arteriosclerosis
| Article | Year |
|---|---|
A multicentre comparative study of serum lipids and apolipoproteins in long-term users of DMPA and a control group of IUD users. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility Regulation Special Programme of Research, D
Topics: Adult; Apolipoprotein A-I; Apolipoprotein A-II; Apolipoproteins; Apolipoproteins B; Arteriosclerosis; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Injections; Intrauterine Devices; Lipids; Medroxyprogesterone Acetate; Mexico; New Zealand; Risk Factors; Thailand; Time Factors; Triglycerides | 1993 |
Hormone replacement therapy and endometrial cancer: are current regimens safe?
Topics: Arteriosclerosis; Bone Density; Coronary Disease; Endometrial Neoplasms; Estrogen Replacement Therapy; Estrogens; Female; Humans; Medroxyprogesterone Acetate; Risk | 1997 |
Plasma homocysteine in women taking hormone replacement therapy: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial.
Topics: Arteriosclerosis; Coronary Artery Disease; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Homocysteine; Humans; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Risk Factors | 1999 |
[Secondary and tertiary prevention of atherosclerotic vessel disease].
Topics: Aged; Arteriosclerosis; Blood Pressure; Coronary Disease; Double-Blind Method; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Postmenopause; Prospective Studies; Time Factors | 2000 |
14 other study(ies) available for medroxyprogesterone acetate and Arteriosclerosis
| Article | Year |
|---|---|
Lack of stimulatory effect of dienogest on the expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 by endothelial cell as compared with other synthetic progestins.
Topics: Arteriosclerosis; Cells, Cultured; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Female; Humans; Intercellular Adhesion Molecule-1; Interleukin-1; Levonorgestrel; Medroxyprogesterone Acetate; Nandrolone; Norethindrone; Norethindrone Acetate; Progesterone Congeners; Receptors, Androgen; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; Umbilical Veins; Vascular Cell Adhesion Molecule-1 | 2002 |
Effects of tibolone and conjugated equine estrogens with or without medroxyprogesterone acetate on body composition and fasting carbohydrate measures in surgically postmenopausal monkeys.
Topics: Animals; Arteriosclerosis; Blood Glucose; Body Composition; Body Weight; C-Peptide; Carbohydrates; Dietary Fats; Energy Intake; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Fasting; Female; Fructosamine; Insulin; Insulin Resistance; Macaca fascicularis; Medroxyprogesterone Acetate; Norpregnenes; Ovariectomy; Postmenopause | 2003 |
Norgestimate and medroxyprogesterone acetate do not attenuate the atheroprotective effects of 17beta-estradiol in ovariectomized, apolipoprotein E-deficient mice.
Topics: Adipose Tissue; Animals; Apolipoproteins E; Arteriosclerosis; Blood Glucose; Body Weight; Dose-Response Relationship, Drug; Estradiol; Female; Insulin; Lipids; Lipoproteins; Medroxyprogesterone Acetate; Mice; Mice, Knockout; Norgestrel; Organ Size; Ovariectomy; Random Allocation; Sinus of Valsalva | 2004 |
Experimental study of the effect on rabbits of the injectable contraceptive medroxyprogesterone acetate, cholesterol feeding and drug-atherogenic diet combination.
Topics: Animals; Aorta; Arteriosclerosis; Cholesterol; Cholesterol, Dietary; Contraceptive Agents, Female; Diet, Atherogenic; Female; Medroxyprogesterone; Medroxyprogesterone Acetate; Rabbits | 1982 |
Regression of atherosclerosis in female monkeys.
Topics: Acetylcholine; Animals; Aorta, Abdominal; Apolipoprotein A-I; Arteriosclerosis; Cholesterol; Cholesterol, Dietary; Cholesterol, HDL; Coronary Circulation; Coronary Vessels; Dietary Fats; Estradiol; Estrogen Replacement Therapy; Female; Lipids; Macaca fascicularis; Medroxyprogesterone Acetate; Ovariectomy; Postmenopause | 1995 |
An examination of the effect of combined cyclical hormone replacement therapy on lipoprotein(a) and other lipoproteins.
Topics: Adult; Apolipoproteins; Arteriosclerosis; Biomarkers; Cardiovascular Diseases; Cholesterol; Drug Administration Schedule; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Follicle Stimulating Hormone; Hong Kong; Humans; Lipoprotein(a); Lipoproteins; Longitudinal Studies; Luteinizing Hormone; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Risk Factors; Triglycerides | 1996 |
The effects of hormone replacement therapy on carbohydrate metabolism and cardiovascular risk factors in surgically postmenopausal cynomolgus monkeys.
Topics: Adipose Tissue; Animals; Arteriosclerosis; Body Composition; Carbohydrate Metabolism; Cardiovascular Diseases; Estrogen Replacement Therapy; Estrogens; Female; Glycation End Products, Advanced; Horses; Macaca fascicularis; Medroxyprogesterone Acetate; Ovariectomy; Postmenopause; Postoperative Period; Risk Factors | 1996 |
The effect of hormone replacement therapy on vitamin E status in postmenopausal women.
Topics: Antioxidants; Arteriosclerosis; Cell Membrane; Chromatography, High Pressure Liquid; Contraceptives, Oral; Erythrocytes; Estradiol Congeners; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Estrone; Female; Follow-Up Studies; Humans; Incidence; Lipids; Lipoproteins, LDL; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Progesterone Congeners; Vitamin E | 1997 |
Conjugated equine estrogens alone, but not in combination with medroxyprogesterone acetate, inhibit aortic connective tissue remodeling after plasma lipid lowering in female monkeys.
Topics: Animals; Aorta; Arteriosclerosis; Cholesterol; Cholesterol, Dietary; Collagen; Connective Tissue; Dietary Fats; Drug Interactions; Elastin; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Horses; Lipids; Macaca fascicularis; Medroxyprogesterone Acetate; Minerals; Ovariectomy | 1998 |
The effects of different doses of medroxyprogesterone acetate on serum lipids, lipoprotein levels and atherogenic index in the menopausal period.
Topics: Arteriosclerosis; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Dose-Response Relationship, Drug; Estrogen Replacement Therapy; Estrogens; Female; Humans; Lipids; Medroxyprogesterone Acetate; Menopause; Middle Aged; Triglycerides | 1998 |
Effect of estrogen and progesterone on gene expression of growth regulatory molecules and proto-oncogene in vascular smooth muscle cells.
Topics: Arteriosclerosis; Blotting, Southern; Cells, Cultured; Drug Interactions; Estrone; Gene Expression Regulation, Developmental; Humans; Interleukin-1; Interleukin-6; Medroxyprogesterone Acetate; Muscle Development; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; Proto-Oncogene Mas; Proto-Oncogene Proteins c-myc; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2000 |
The Heart and Estrogen/Progestin Replacement Study (HERS) in perspective--results not very surprising.
Topics: Aged; Arteriosclerosis; Cardiovascular Diseases; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Progesterone Congeners; Randomized Controlled Trials as Topic; Reproducibility of Results; Survival Analysis | 2000 |
The relation of oxidized LDL autoantibodies and long-term hormone replacement therapy to ultrasonographically assessed atherosclerotic plaque quantity and severity in postmenopausal women.
Topics: Aged; Arteries; Arteriosclerosis; Autoantibodies; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Humans; Levonorgestrel; Lipoproteins, LDL; Medroxyprogesterone Acetate; Menopause; Middle Aged; Postmenopause; Progesterone Congeners; Reference Values; Severity of Illness Index; Time Factors; Ultrasonography | 2001 |
Effect of depo-medroxyprogesterone acetate on coagulation factors and serum lipids in Egyptian women.
Topics: Adult; Antithrombin III; Arteriosclerosis; Blood Coagulation Factors; Cholesterol; Contraceptive Agents, Female; Delayed-Action Preparations; Egypt; Female; Humans; Lipids; Longitudinal Studies; Medroxyprogesterone; Medroxyprogesterone Acetate; Prospective Studies; Risk Factors; Thrombosis; Time Factors; Triglycerides | 1991 |